Asthma & COPD Market, By Drug Type (Bronchodilators (Short Acting Bronchodilators, Long Acting Bronchodilators, Anticholinergics), Anti-Inflammatories (Inhaled Corticosteroids, Anti-Leukotriene, Monoclonal Antibodies), Combination Therapies), By Disease Type (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), and By Region (North America, Latin America, Europe Asia, Pacific Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Asthma is a type of chronic respiratory disease, which is characterized by attacks of breathlessness and wheezing. Asthma can occur at any stage, though it is the most common disease in children. Asthma attacks are linked to respiratory infections and environmental factors such as allergens, tobacco, smoke, and indoor and outdoor pollution. Indoor pollution factors include mold, chemicals, strong odors, and house dust whereas outdoor pollution factors include air pollution, allergens, tobacco, and smoking. Such factors are responsible for development and exacerbation of asthma.
Restraints of the Global Asthma and COPD Market
Major factors hampering the growth of the asthma and COPD market during the forecast period constitutes of patent losses, and high costs.
Key features of the study:
This report provides in-depth analysis of the global asthma and COPD market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global asthma and COPD market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Asthma and COPD Market, By Drug Type:
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
Global Asthma and COPD Market, By Disease Type:
Asthma
COPD
Global Asthma and COPD Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Global Asthma and COPD Market, By Geography:
North America
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
U.S.
Canada
Europe
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country:
GCC
Israel
Rest of Middle East
Africa
By Drug Type
Bronchodilators
Short Acting Bronchodilators
Long Acting Bronchodilators
Anticholinergics
Anti-Inflammatories
Inhaled Corticosteroids
Anti-Leukotriene
Monoclonal Antibodies
Combination Therapies
By Disease Type
Asthma
COPD
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
AstraZeneca PLC*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Novartis AG
GlaxoSmithKline plc
Merck & Co., Inc.
Verona Pharma plc
Regeneron Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
“*” marked represents similar segmentation in other categories in the respective section.
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Disease Type
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- 4. Global Asthma and COPD Market, By Drug Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Short Acting Bronchodilators
- Long Acting Bronchodilators
- Anticholinergics
- Anti-Inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Inhaled Corticosteroids
- Anti-Leukotriene
- Monoclonal Antibodies
- Combination Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- 5. Global Asthma and COPD Market, By Disease Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 6. Global Asthma and COPD Market, By Distribution Channel, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- 7. Global Asthma and COPD Market, By Regions, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 8. Competitive Landscape
- Company Profiles
- AstraZeneca PLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Verona Pharma plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim GmbH
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 32 market data tables and 27 figures on “Asthma and COPD Market – Global forecast to 2027.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook